| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Presentation > We Don't Do Presentations |
|
Advice Pool - We Don't Do Presentations
... we just have meetings. Seriously? I've come across that comment a few times in the last year or so and I've never challenged it at the time: there are too many people around who recognise According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product that they need help to spend time worrying about those who think they don't. And yet at the back of my mind I'm aware of a slightly guilty feeling. After all, just because these people don't th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ink they - or their staff - are making presentations doesn't mean they don't need help at it. In fact there's an argument to suggest that precisely because of this belief they're more likely lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. han most to need help! Because I'm that sad kind of person, I lay awake at night mulling this idea over. Perhaps they were right and there really are no presentations of any kind in their place of work here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe . Perhaps no-one ever had to provide information to anyone else face-to-face in an even semi-structured way. Perhaps they never met each other on the corridor and asked each other how things were going d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro and updated each other on the progress of this-or-that-project. Perhaps they did everything in a completely organic (indeed anarchic!) way. Perhaps their sales and PR staff never have to meet the publ ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc c or potential clients. Perhaps. But I didn't think so. I've never seen and organisation like this and I don't expect I ever will. So why do people tell me they don't do presentations (often with a b easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi it of a sneer, trying to tell me that they thought I was a bit of a fool for suggesting it)? I guess it boils down to definitions. My definition of a presentation is - as you'll have guessed - pretty c nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically atholic. It's about the process, not the place. It can take place formally, when everyone is sitting down and facing the speaker as he or she fights with nerves and notes, or it can be done informally, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ perhaps as people pass on corridors, at water coolers or (as I've seen more times than people will believe) going into or out of the office toilets! In such times, people aren't worried about the pro ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi cess of presenting itself (they've got more important things on their minds), such as getting a coffee, a cold water, or washing their hands) and so all they have to do is "get on with" passing on th ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e information. I can remember a book I read a long time ago. The (anti-) hero is being asked by another character to teach her to fight. He declines but is eventually hounded into agreeing to a challe dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ge: he agrees to throw an orange and if the woman asking for training successfully catches it, he must train her. If she fails, she goes away and never bothers him again. The stakes are high. He throw cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s and she catches. Annoyed, the hero asks her what she's just done: she's exhaulted and talks breathlessly about winning the right to be trained, to stay, to become a master like him; she talks about be tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ating the odds and about defying his expectations. He shakes his head and points out that at that moment, when he threw, none of those things were happening. At that moment, all she did was catc t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the orange. Presentations are kind of like that. Just catch the orange. The stakes aren't important. And that's how these people can present at the water cooler but not in the boardroom. When the s ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust takes are higher they forget that all they've got to do is catch the orange and they start to get hooked up on the idea of what they might win. And what they have to lose. Let's not get carried away, b y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products y the way: there's a skill to catching oranges which people need to be taught and they need to practice: it's not as easy as all that. If it was, I'd be out of a job, but there are three steps to making . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de better business presentations, I'd suggest. 1 - recognise that you make them. I've never met anyone who made none. 2 - recognise that you just need to catch the orange; the consequences will take care elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip of themselves 3 - get some training on how to catch oranges if it's important to you or if you ever drop them We all make presentations, we all catch (or drop!) oranges..... just a thought.... Simo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Las Vegas Private Investigator Job Search - Understand Employers
|